The role of thrombosis in severe pulmonary hypertension

Considering the important surface in pulmonary circulation where blood can interact with the endothelium, the maintenance of blood fluidity through the lung, by antithrombotic pathways and products of the endothelium, is essential. This function appears to be ineffective in primary pulmonary hypertension and in severe secondary pulmonary hypertension. Thrombotic lesions are frequently found in pulmonary arteries in these diseases. Thrombin activity appears to be increased in severe pulmonary hypertension. Antithrombotic pathway disorders may account for this abnormality, particularly in chronic thromboembolic pulmonary hypertension and primary pulmonary hypertension. Injured endothelium, a constant feature in severe pulmonary hypertension, either primary or secondary, enhances thrombus formation in pulmonary vessels. This is probably related to thrombomodulin and tissue factor imbalance, impairment of prostacyclin and nitric oxide release, as well as inefficiency of fibrinolysis. Moreover, platelets appear to be activated in the pulmonary circulation of these patients. They release several mediators acting on vascular tone and as mitogenic agents, and may also contribute to thrombin and clot generation. Long-term oral anticoagulant and continuous infusion of prostacyclin, treatments which impede thrombosis, are known to improve the survival rate in patients with primary pulmonary hypertension. These are the strongest arguments, so far, in favour of the role of thrombosis in severe pulmonary hypertension. However, we do not know whether these abnormalities result from a previous vascular injury or represent the primary disturbance.

This article has been cited by other articles:

				B. Bakouboula, O. Morel, A. Faure, F. Zobairi, L. Jesel, A. Trinh, M. Zupan, M. Canuet, L. Grunebaum, A. Brunette, et al. Procoagulant Membrane Microparticles Correlate with the Severity of Pulmonary Arterial Hypertension Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 536 - 543. [Abstract] [Full Text] [PDF]

				H. A. Ghofrani, R. Voswinckel, F. Reichenberger, N. Weissmann, R. T. Schermuly, W. Seeger, and F. Grimminger Hypoxia- and non-hypoxia-related pulmonary hypertension - Established and new therapies Cardiovasc Res, October 1, 2006; 72(1): 30 - 40. [Abstract] [Full Text] [PDF]

				N. Galie and N. H. S. Kim Pulmonary Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension Proceedings of the ATS, September 1, 2006; 3(7): 571 - 576. [Abstract] [Full Text] [PDF]

				L. J. Rubin, M. M. Hoeper, W. Klepetko, N. Galie, I. M. Lang, and G. Simonneau Current and Future Management of Chronic Thromboembolic Pulmonary Hypertension: From Diagnosis to Treatment Responses Proceedings of the ATS, September 1, 2006; 3(7): 601 - 607. [Abstract] [Full Text] [PDF]

				A. Peacock, G. Simonneau, and L. Rubin Controversies, Uncertainties and Future Research on the Treatment of Chronic Thromboembolic Pulmonary Hypertension Proceedings of the ATS, September 1, 2006; 3(7): 608 - 614. [Abstract] [Full Text] [PDF]

				S. R. Johnson, J. T. Granton, and S. Mehta Thrombotic Arteriopathy and Anticoagulation in Pulmonary Hypertension. Chest, August 1, 2006; 130(2): 545 - 552. [Abstract] [Full Text] [PDF]

				L. H. Caramuru, A. A. Lopes, N. Y. Maeda, V. D. Aiello, and C. C. Filho Long-term Behavior of Endothelial and Coagulation Markers in Eisenmenger Syndrome Clinical and Applied Thrombosis/Hemostasis, April 1, 2006; 12(2): 175 - 183. [Abstract] [PDF]

				R. S. BelAiba, T. Djordjevic, S. Bonello, F. Artunc, F. Lang, J. Hess, and A. Gorlach The Serum- and Glucocorticoid-Inducible Kinase Sgk-1 Is Involved in Pulmonary Vascular Remodeling: Role in Redox-Sensitive Regulation of Tissue Factor by Thrombin Circ. Res., March 31, 2006; 98(6): 828 - 836. [Abstract] [Full Text] [PDF]

				M. M. Hoeper, T. Kramm, H. Wilkens, C. Schulze, H. J. Schafers, T. Welte, and E. Mayer Bosentan Therapy for Inoperable Chronic Thromboembolic Pulmonary Hypertension Chest, October 1, 2005; 128(4): 2363 - 2367. [Abstract] [Full Text] [PDF]

				P. Dartevelle, E. Fadel, S. Mussot, A. Chapelier, P. Herve, M. de Perrot, J. Cerrina, F.L. Ladurie, D. Lehouerou, M. Humbert, et al. Chronic thromboembolic pulmonary hypertension Eur. Respir. J., April 1, 2004; 23(4): 637 - 648. [Abstract] [Full Text] [PDF]

				L. H. Caramuru, R. D. P. S. Soares, N. Y. Maeda, and A. A. Lopes Hypoxia and Altered Platelet Behavior Influence von Willebrand Factor Multimeric Composition in Secondary Pulmonary Hypertension Clinical and Applied Thrombosis/Hemostasis, July 1, 2003; 9(3): 251 - 258. [Abstract] [PDF]

				H. A. Ghofrani, R. T. Schermuly, F. Rose, R. Wiedemann, M. G. Kohstall, A. Kreckel, H. Olschewski, N. Weissmann, B. Enke, S. Ghofrani, et al. Sildenafil for Long-Term Treatment of Nonoperable Chronic Thromboembolic Pulmonary Hypertension Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1139 - 1141. [Abstract] [Full Text] [PDF]

				D. Shitrit, D. Bendayan, A. Bar-Gil-Shitrit, M. Huerta, B. Rudensky, G. Fink, and M. R. Kramer Significance of a Plasma D-dimer Test in Patients With Primary Pulmonary Hypertension Chest, November 1, 2002; 122(5): 1674 - 1678. [Abstract] [Full Text] [PDF]

				A. A. Lopes, L. H. Caramuru, and N. Y. Maeda Endothelial Dysfunction Associated with Chronic Intravascular Coagulation in Secondary Pulmonary Hypertension Clinical and Applied Thrombosis/Hemostasis, October 1, 2002; 8(4): 353 - 358. [Abstract] [PDF]

				K. Chatterjee, T. De Marco, and J. S. Alpert Pulmonary Hypertension: Hemodynamic Diagnosis and Management Arch Intern Med, September 23, 2002; 162(17): 1925 - 1933. [Abstract] [Full Text] [PDF]

				A.T. Dinh-Xuan, M. Humbert, and R. Naeije Severe pulmonary hypertension: walking through new paths to revisit an old field Eur. Respir. J., September 1, 2002; 20(3): 509 - 510. [Full Text] [PDF]

				M. Ueno, T. Miyauchi, S. Sakai, R. Yamauchi-Kohno, K. Goto, and I. Yamaguchi A combination of oral endothelin-areceptor antagonist and oral prostacyclinanalogue is superior to each drug alone inameliorating pulmonary hypertension in rats J. Am. Coll. Cardiol., July 3, 2002; 40(1): 175 - 181. [Abstract] [Full Text] [PDF]

				M. Beghetti, G. Reber, P. de Moerloose, L. Vadas, A. Chiappe, I. Spahr-Schopfer, and P.C. Rimensberger Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation Eur. Respir. J., March 1, 2002; 19(3): 518 - 524. [Abstract] [Full Text] [PDF]

				J.-C. Murciano, D. Harshaw, D. G. Neschis, L. Koniaris, K. Bdeir, S. Medinilla, A. B. Fisher, M. A. Golden, D. B. Cines, M. T. Nakada, et al. Platelets inhibit the lysis of pulmonary microemboli Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L529 - L539. [Abstract] [Full Text] [PDF]

				G Espinosa, R Cervera, J Font, and R A Asherson The lung in the antiphospholipid syndrome Ann Rheum Dis, March 1, 2002; 61(3): 195 - 198. [Abstract] [Full Text] [PDF]

				J. M. Edelberg, P. D. Christie, and R. D. Rosenberg Regulation of Vascular Bed-Specific Prothrombotic Potential Circ. Res., July 20, 2001; 89(2): 117 - 124. [Abstract] [Full Text] [PDF]

				A. Kereveur, J. Callebert, M. Humbert, P. Herve, G. Simonneau, J.-M. Launay, and L. Drouet High Plasma Serotonin Levels in Primary Pulmonary Hypertension : Effect of Long-Term Epoprostenol (Prostacyclin) Therapy Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20(10): 2233 - 2239. [Abstract] [Full Text] [PDF]

				R. J Stratton, L. Pompon, J. G Coghlan, J. D Pearson, and C. M Black Soluble thrombomodulin concentration is raised in scleroderma associated pulmonary hypertension Ann Rheum Dis, February 1, 2000; 59(2): 132 - 134. [Abstract] [Full Text]

				A. Russo, M. De Luca, C. Vigna, Vincenzo De Rito, M. Pacilli, A. Lombardo, M. Armillotta, R. Fanelli, and F. Loperfido Central Pulmonary Artery Lesions in Chronic Obstructive Pulmonary Disease : A Transesophageal Echocardiography Study Circulation, October 26, 1999; 100(17): 1808 - 1815. [Abstract] [Full Text] [PDF]

				U. R. Pendurthi, L. V. M. Rao, J. T. Williams, and S. Idell Regulation of Tissue Factor Pathway Inhibitor Expression in Smooth Muscle Cells Blood, July 15, 1999; 94(2): 579 - 586. [Abstract] [Full Text] [PDF]

				P. Egermayer, G I. Town, and A. J Peacock Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension Thorax, February 1, 1999; 54(2): 161 - 168. [Full Text]

				Z. Nong, M. Hoylaerts, N. Van Pelt, D. Collen, and S. Janssens Nitric Oxide Inhalation Inhibits Platelet Aggregation and Platelet-Mediated Pulmonary Thrombosis in Rats Circ. Res., November 19, 1997; 81(5): 865 - 869. [Abstract] [Full Text]